Following on from good Phase 2 trials (see here) Israel’s Sol-Gel reported excellent results from pivotal Phase 3 clinical trials of its Twyneo treatment of patients with acne vulgaris. The trial significantly reduced moderate-to-severe acne in 858 patients aged nine and older.

http://ir.sol-gel.com/news-releases/news-release-details/sol-gel-announces-positive-top-line-phase-3-trial-results